Bespak Injectables specialises in the design, development and supply of innovative devices for the delivery of injectable drug products. Through its proprietary self-injection platforms, Bespak Injectables offers customised injection devices for specific applications, as well as off-the-shelf products.
Our current patented technology portfolio includes both auto injectors and needle-free jet injectors. By combining ease-of-use, versatility, cost-effectiveness and safety, Bespak Injectables' self-injection technologies offer the means for creating competitive advantage for our pharmaceutical and biotechnology industry partners.
The ASI auto injector is a single-use disposable auto injector platform, which is readily customisable for delivery of both biologic and small molecule drugs in either elective or emergency therapies.
The key advantages offered by the ASI auto injector platform are:
Bespak Injectables has developed an off-the-shelf single-use disposable auto injector, based on a commonly-used syringe, needle and dose volume combination. The device encompasses all the advantages of the ASI auto injector platform, enabling non-clinicians to safely undertake injections by means of an easy-to-use device, an automated injection process and the capture of the needle inside the used auto injector.
Bespak Injectables' single-use disposable auto injector features audible, visual and tactile cues to inform the user of the status of the injection process. Devices can be configured for either three-step (button-actuated) or two-step (push-actuated) operation, thus allowing flexibility to address the needs of specific patient populations and therapies. Our off-the-shelf device allows our partners to undertake handling studies and user trials in a timely manner.
Bespak Injectables' reusable needle-free jet injectors utilise spring power to inject liquid drugs without the use of a needle. A fine stream of liquid is forced through an orifice in a specially designed nozzle, with the velocity of this stream enabling the liquid drug to penetrate the tissue to the required depth.
The key advantages of Bespak Injectables' needle-free jet injectors are:
Bespak Injectables has developed the cool.click2 needle-free growth hormone injector for our partner, Merck Serono. The cool.click2 was launched in the US and Europe in 2009.
Bespak Injectables (formerly The Medical House) was acquired in 2009 by Consort Medical PLC. Consort operates state-of-the-art medical device manufacturing facilities in the US and UK, and its Bespak division is a leading supplier of drug delivery devices to the global pharmaceutical industry. Bespak Injectables can offer a comprehensive capability incorporating:
This capability provides the basis for effective, long-term relationships, from early device development through to commercialisation and product lifecycle management.